Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > TH's website issues

<< Previous

Bullboard Posts

Next >>

Comment by Wino115on Apr 25, 2021 9:28am

148 Views

Post# 33063102

RE:RE:RE:RE:TH's website issues

Good news - Contact was initiated late Friday, so at some point the conversation will be arranged; likely this week.

SPCEO1 wrote: I have to believe the chances of such an outcome are pretty high and hope that is how it plays out. But we await them being willing to speak to Wino and for Wino to report back to us all. If they are not willing to speak with him (I would be surprised if that were the case) or if he comes away concerned rather than relieved, then we will have to give a hard think as to how to vote.